| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 04/08/2009 | CN101402609A Method for synthesis of 5-bromine-3-sec-butyl-6- methyl uracil |
| 04/08/2009 | CN101402603A Polyhalogenated heterocycle ketene peptide derivative and synthesis thereof |
| 04/08/2009 | CN100475799C Merocyanine derivatives for cosmetic use |
| 04/08/2009 | CN100475793C Quinazoline derivatives and use for preparing medicine |
| 04/08/2009 | CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/07/2009 | US7514565 3,5-Difluoropyridines |
| 04/07/2009 | US7514447 e.g. [2-(4-Isopropyl-piperazin-1-yl)-benzooxazol-6-yl]-[5-(4-methoxy-phenyl)-pyrimidin-2-yl]-amine; C-kit kinase receptor or stem cell factor inhibitors; anticarcinogenic agents; veterinary medicine |
| 04/07/2009 | US7514446 antineoplastic/antimitotic agents; inhibit proliferation of the cell; breast cancer, colon cancer, lung cancer, prostate cancer, lymphoma, leukemia, endometrial cancer, melanoma; Polo-like kinase inhibitors; 2-({5-nitro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)benzoic acid hydrochloride |
| 04/07/2009 | US7514445 Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors) |
| 04/07/2009 | US7514098 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 04/07/2009 | CA2400554C Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 04/07/2009 | CA2358940C Method of producing thiobarbituric acid derivatives |
| 04/07/2009 | CA2348374C Method for producing 4- [(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols |
| 04/07/2009 | CA2300424C Hiv nuclear localization inhibitors |
| 04/07/2009 | CA2297112C Dicyclanil polymorphs and hydrates and their preparation |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/07/2009 | CA2210252C Crystalline trimetrexate salts and the process for making the same |
| 04/02/2009 | WO2009042139A1 2-s-benzyl substituted pyrimidines as crth2 antagonists |
| 04/02/2009 | WO2009042138A1 Alkylthio pyrimidines as crth2 antagonists |
| 04/02/2009 | WO2009041566A1 Preventive or remedy for posterior eye diseases containing quinazolinone derivative or quinoxaline derivative as the active ingredient |
| 04/02/2009 | WO2009041565A1 Quinazolinone derivative, and prophylactic or therapeutic agent for corneal/conjunctival disorder comprising quinazolinone derivative as active ingredient |
| 04/02/2009 | WO2009040590A1 Complex product with advanced assimilation efficacy for humans and its utilization |
| 04/02/2009 | WO2009040288A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 04/02/2009 | WO2008157537A3 Compositions and methods of use for treating or preventing lipid related disorders |
| 04/02/2009 | WO2008104994A3 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 04/02/2009 | US20090088571 Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides |
| 04/02/2009 | US20090088570 Organic electroluminescent device |
| 04/02/2009 | US20090088420 Compounds with hiv-1 integrase inhibitory activity and use thereof as anti-hiv/aids therapeutics |
| 04/02/2009 | US20090088397 Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus |
| 04/02/2009 | US20090088322 e.g.4-Amino-6-(4-chlorophenyl)-5-fluoro-3-vinylpyridine-2-carboxylic acid; 4-Acetylamino-6-(4-chloro-2-fluoro-3-methoxyphenyl)-3-trimethylsilanylethynylpyridine-2-carboxylic acid methyl ester; |
| 04/02/2009 | CA2700727A1 Complex product with advanced assimilation efficacy for humans and its utilization |
| 04/02/2009 | CA2700525A1 2-s-benzyl substituted pyrimidines as crth2 antagonists |
| 04/02/2009 | CA2700524A1 Alkylthio pyrimidines as crth2 antagonists |
| 04/02/2009 | CA2700277A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 04/01/2009 | EP2042488A1 Matrix metalloproteinase inhibitors |
| 04/01/2009 | EP2042171A1 Therapeutic or prophylactic agent for allergic dermatitis |
| 04/01/2009 | EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases |
| 04/01/2009 | EP2041093A1 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases |
| 04/01/2009 | EP2041079A1 Arylsulfonyl naphthalene derivatives and uses thereof |
| 04/01/2009 | EP2040549A2 Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor |
| 04/01/2009 | EP1660431B1 Phenoxyacetic acid derivatives |
| 04/01/2009 | EP1521744B1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 04/01/2009 | EP1082308B1 Heterocyclically substituted amides used as calpain inhibitors |
| 03/31/2009 | US7511149 Using ruthenium tetraoxide and alkali metal permanganate |
| 03/31/2009 | US7511140 Process for preparing the calcium salt of rosuvastatin |
| 03/31/2009 | US7511137 Stereoisomers and stereoisomeric mixtures of 1-(2,4-pyrimidinediamino)-2-cyclopentanecarboxamide synthetic intermediates |
| 03/31/2009 | US7511052 N-[2-diethylamino-5-{N-ethyl-N-(trifluoroacetyl)amino}pyrimidin-4-yl]-L-4'-{(pyrrolidin-1-yl)carbonyloxy}phenylalanine; antiinflammatory agent; asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation |
| 03/31/2009 | US7511050 hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors; avoiding adverse effects such as hepatotoxicity and cutaneous flushing; low dosage; 2-bromo-8-methyl-4-pentyl-1,4-dihydro-5H-[1,2,4]triazolo[5,1-i]purin-5-one; to treat cardiovascular disorders |
| 03/31/2009 | US7511048 Hyperproliferative disorders; packages |
| 03/31/2009 | US7511041 Fused azole-pyrimidine derivatives |
| 03/31/2009 | US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 03/31/2009 | CA2458679C Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives |
| 03/31/2009 | CA2448602C Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/31/2009 | CA2417897C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 03/31/2009 | CA2356121C Novel propargylether derivatives |
| 03/26/2009 | WO2009039135A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 03/26/2009 | WO2009039134A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | WO2009039127A1 Uracil or thymine derivative for treating hepatitis c |
| 03/26/2009 | WO2009037473A2 Nucleobase characterisation |
| 03/26/2009 | WO2009036996A2 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | WO2009009793A3 Inhibitors of akt/pkb with anti-tumor activity |
| 03/26/2009 | WO2008122776A3 Process for preparation of erlotinib and its pharmaceutically acceptable salts |
| 03/26/2009 | US20090082567 2,4-pyrimidinediamine compounds and their uses |
| 03/26/2009 | US20090082380 Deuterium-enriched rosuvastatin |
| 03/26/2009 | US20090082377 Matrix Metalloproteinase Inhibitors |
| 03/26/2009 | US20090082376 Deuterium-enriched alogliptin |
| 03/26/2009 | US20090082365 Trisubstituted Quinazolinone Derivatives as Vanilloid Antagonists |
| 03/26/2009 | US20090082356 Pyrazine Derivatives and Use as P13k Inhibitors |
| 03/26/2009 | US20090082352 Novel pyrimidine compound having dibenzylamine structure and medicament comprising the same |
| 03/26/2009 | US20090082351 Pesticide pyrimidinyloxy substituted phenylamidine derivatives |
| 03/26/2009 | US20090082339 Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| 03/26/2009 | US20090081145 Process for forming disulphide bridges |
| 03/26/2009 | US20090080074 Polymer film, polarizing plate protective film, polarizing plate and liquid crystal display device |
| 03/26/2009 | US20090079343 Organic electroluminescent device |
| 03/26/2009 | CA2700158A1 3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses |
| 03/26/2009 | CA2700082A1 Nucleobase characterisation |
| 03/26/2009 | CA2700051A1 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | CA2699989A1 N-phenyl-dioxo-hydro pyrimidines useful as hepatitis c virus (hcv) inhibitor |
| 03/26/2009 | CA2699986A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | CA2699981A1 Uracil or thymine derivative for treating hepatitis c |
| 03/25/2009 | EP2039687A1 Therapeutic or prophylactic agent for multiple sclerosis |
| 03/25/2009 | EP2039683A2 Vasculostatic agents and methods of use thereof |
| 03/25/2009 | EP2037930A1 The use of 1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertension |
| 03/25/2009 | EP1357113B1 6-(1-fluoroethyl)-5-iodo-4-aminopyrimidine compounds, process for preparation of the same, and pest controllers for agricultural and horticultural use |
| 03/25/2009 | CN101394743A Use of sulfonanilides as herbicide |
| 03/25/2009 | CN101391984A Method for carrying out methylation to pyrimidine heterocyclic compound containing sulfhydryl by dimethyl carbonate |
| 03/25/2009 | CN101391983A Amino pyrimidines compounds and synthetic method thereof |
| 03/25/2009 | CN100471846C Cyanoacrylate compounds and their application in pesticide |
| 03/25/2009 | CN100471843C Superhigh purity ionic liquid |
| 03/24/2009 | US7507822 Cyclizing, halogenating by reacting in presence of catalytic amount of metal halide and dehydrating agent |
| 03/24/2009 | US7507821 2-chloro-4-(3-pyridyl)-pyrimidine is reacted with 2-amino-4-nitrotoluene to obtain N-(2-methyl-5-nitrophenyl)-4-(3-pyridyl)-2-pyrimidine-amine, hydrogenated to N-(5-amino-2-methyl)-4-(3-pyridyl)-pyrimidine-amine, reacted with 4-(4-methyl-piperazine-1-ylmethyl)-benzoyl chloride; avoids use of cyanamide |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507742 Spirocyclic derivatives |
| 03/24/2009 | US7507741 Heterocyclic compounds |
| 03/24/2009 | US7507738 Intermediates to anticancer agents, NK1 antagonists, or elastase inhibitors; 2-(alkoxy, aryl, alkyl, alkylamino or alkylthio)-6-oxo-5-(protected amino)-1,6-dihydropyrimidine by reacting an N-protected glycine ester with dimethylformamidedimethylacetal, reacting with acid and then amidine compound |
| 03/24/2009 | US7507733 11b-HSD1 inhibitors for the treatment of diabetes |
| 03/24/2009 | CA2437501C Process for the manufacture of phenylacetic acid derivatives |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/19/2009 | WO2009034390A1 Heterocyclic derivatives and their use in treating hepatitis c |